[1] Chen GY, Li L, Dai F, et al.Prevalence of and risk factors for type 2 diabetes mellitus in hyperlipidemia in China[J]. Med Sci Monit,2015,21:2476-2484. [2] Yang SH, Dou KF, Song WJ.Prevalence of diabetes among men and women in China[J]. N Engl J Med,2010, 362(25):2425-2426. [3] Cornelis MC, Zaitlen N, Hu FB, et al.Genetic and environmental components of family history in type 2 diabetes[J]. Hum Genet,2015,134(2):259-267. [4] Greig SL, Scott LJ.Insulin degludec/liraglutide: A review in type 2 diabetes[J]. Drugs,2015,75(13):1523-1534. [5] Jin W, Goldfine AB, Boes T, et al.Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance[J]. J Clin Invest,2011, 121(3):918-929. [6] Diboun I, Wernisch L, Orengo CA, et al.Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma[J]. BMC Genomics,2006,7:252. [7] Papazafiropoulou AK, Papanas N, Melidonis A, et al. Family history of type 2 diabetes: does having a diabetic parent increase the risk?[J/OL]. Curr Diabetes Rev,2015-10-22[2016-06-20].http://www.ncbi.nlm.nih.gov/pubmed/26490432. [8] Himsworth HP.Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. 1936[J]. Int J Epidemiol,2013,42(6):1594-1598. [9] Karnieli O, Izhar-Prato Y, Bulvik S, et al.Generation of insulin-producing cells from human bone marrow mesen-chymal stem cells by genetic manipulation[J]. Stem Cells,2007,25(11):2837-2844. [10] Ding Y, Xu D, Feng G, et al.Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and-9[J]. Diabetes,2009,58(8):1797-1806. [11] Lee RH, Seo MJ, Reger RL, et al.Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice[J]. Proc Natl Acad Sci U S A,2006,103(46):17438-17443. [12] Duran-Salgado MB, Rubio-Guerra AF.Diabetic nephropathy and inflammation[J]. World J Diabetes,2014, 5(3):393-398. [13] Wu CC, Sytwu HK, Lu KC, et al.Role of T cells in type 2 diabetic nephropathy[J]. Exp Diabetes Res,2011,2011:514738. [14] Abouzeid S, Sherif N.Role of alteration in Treg/Th17 cells' balance in nephropathic patients with Type 2 diabetes mellitus[J]. Electron Physician,2015,7(8):1613-1618. [15] Zhai X, Qian G, Wang Y, et al.Elevated B cell activation is associated with type 2 diabetes development in obese subjects[J]. Cell Physiol Biochem,2016,38(3):1257-1266. [16] Li D, Lu Z, Jia J, et al.MiR-124 is related to podocytic adhesive capacity damage in STZ-induced uninephrectomized diabetic rats[J]. Kidney Blood Press Res,2013, 37(4-5):422-431. [17] Li D, Lu Z, Jia J, et al.Curcumin ameliorates podocytic adhesive capacity damage under mechanical stress by inhibiting miR-124 expression[J]. Kidney Blood Press Res,2013,38(1):61-71. |